Skip to main content
. 2021 Nov 23;118(48):e2105021118. doi: 10.1073/pnas.2105021118

Fig. 4.

Fig. 4.

KEGG pathways associated with the 83 metabolites differently produced in ahp2,3,5 and arr1,10,12 mutants, relative to WT plants, grown under nonsaline (ahp2,3,5-C/WT-C and arr1,10,12-C/WT-C) and saline (ahp2,3,5-S/WT-S and arr1,10,12-S/WT-S comparisons) conditions. The metabolite production levels in the heatmaps are a z-score–normalized data matrix. KEGG IDs of the DPMs were submitted to KEGG mapper to identify specific pathways. Red and blue colors indicate increased and decreased levels of metabolites, respectively, as indicated by the colored scales. 4-amino-butyrate, GABA; cyanidin 3-O-[2-O-(β-d-xylopyranosyl)-6-O-(E-p-coumaroyl)-β-d-glucopyranoside]-5-O-[6-O-(malonyl)-β-d-glucopyranoside], A5; cyanidin 3-O-[2-O-(2-O-(E-sinapoyl)-β-d-xylopyranosyl)-6-O-(4-O-E-p-coumaroyl)-β-d-glucopyranoside]-5-O-[6-O-(malonyl)-β-d-glucopyranoside], A9; cyanidin 3-O-[2-O-(2-O-(E-sinapoyl)-β-d-xylopyranosyl)-6-O-(4-O-(β-d-glucopyranosyl)-E-p-coumaroyl)-β-d-glucopyranoside]-5-O-[β-d-glucopyranoside], A10; cyanidin 3-O-[2-O-(2-O-(E-sinapoyl-β-d-xylopyranosyl)-6-O-(4-O-(β-d-glucopyranosyl)-(E-p-coumaroyl)-β-d-glucopyranoside)-5-O-[6-O-(malonyl)-β-d-glucopyranoside], A11; kaempferol-diHex-Rha, KHR; kaempferol-3-Rha-7-Glu, KRG; quercetin-3-O-α-L-rhamnopyranosyl(1, 2)-β-D-glucopyranoside-7-O-α-L-rhamnopyranoside, F4; rhamnoside, Rha.